While taking anti-diabetes agents, in combination with drugs that attenuate the hypoglycemic action or drug, or that enhance the hypoglycemic action, it is necessary to pay attention to hypoglycemia and fluctuations in blood glucose levels. Furthermore, a coadministration of two or more anti-diabetes agents including newly coming drugs, especially used in combination with insulin formulations or insulin secretagogues should be closely monitored and may need to reduce the dose.
|ジャーナル||Nihon rinsho. Japanese journal of clinical medicine|
|出版ステータス||Published - 3月 1 2015|
ASJC Scopus subject areas